These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35983098)

  • 1. Predict ovarian cancer by pairing serum miRNAs: Construct of single sample classifiers.
    Hong G; Luo F; Chen Z; Ma L; Lin G; Wu T; Li N; Cai H; Hu T; Zhong H; Guo Y; Li H
    Front Med (Lausanne); 2022; 9():923275. PubMed ID: 35983098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construct of qualitative diagnostic biomarkers specific for glioma by pairing serum microRNAs.
    Li H; Ma L; Luo F; Liu W; Li N; Hu T; Zhong H; Guo Y; Hong G
    BMC Genomics; 2023 Mar; 24(1):96. PubMed ID: 36864382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of diverse cancer types reveals a breast cancer-specific serum miRNA biomarker through relative expression orderings analysis.
    Ma L; Gao Y; Huo Y; Tian T; Hong G; Li H
    Breast Cancer Res Treat; 2024 Apr; 204(3):475-484. PubMed ID: 38191685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-mass-ion discriminant equation (LOME) for ovarian cancer screening.
    Lee JH; Yoo BC; Kim YH; Ahn SA; Yeo SG; Cho JY; Kim KH; Kim SC
    BioData Min; 2016; 9():32. PubMed ID: 27752286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study.
    Lin XJ; Chong Y; Guo ZW; Xie C; Yang XJ; Zhang Q; Li SP; Xiong Y; Yuan Y; Min J; Jia WH; Jie Y; Chen MS; Chen MX; Fang JH; Zeng C; Zhang Y; Guo RP; Wu Y; Lin G; Zheng L; Zhuang SM
    Lancet Oncol; 2015 Jul; 16(7):804-15. PubMed ID: 26088272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential levels of L-homocysteic acid and lysophosphatidylcholine (16:0) in sera of patients with ovarian cancer.
    Kim SC; Kim MK; Kim YH; Ahn SA; Kim KH; Kim K; Kim WK; Lee JH; Cho JY; Yoo BC
    Oncol Lett; 2014 Aug; 8(2):566-574. PubMed ID: 25013471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predict Colon Cancer by Pairing Plasma miRNAs: Establishment of a Normalizer-Free, Cross-Platform Model.
    Qin D; Guo Q; Wei R; Liu S; Zhu S; Zhang S; Min L
    Front Oncol; 2021; 11():561763. PubMed ID: 33968711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential DNA methylation alterations of ovarian cancer in peripheral whole blood based on within-sample relative methylation orderings.
    Li H; Jiang F; Du Y; Li N; Chen Z; Cai H; Guo Y; Hong G
    Epigenetics; 2022 Mar; 17(3):314-326. PubMed ID: 33749504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk score system based on a six-microRNA signature predicts the overall survival of patients with ovarian cancer.
    Zhou M; Wu T; Yuan Y; Dong SJ; Zhang ZM; Wang Y; Wang J
    J Ovarian Res; 2022 May; 15(1):54. PubMed ID: 35513874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying primary site of lung-limited Cancer of unknown primary based on relative gene expression orderings.
    Li M; Li H; Hong G; Tang Z; Liu G; Lin X; Lin M; Qi L; Guo Z
    BMC Cancer; 2019 Jan; 19(1):67. PubMed ID: 30642283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Classifier Based on Urinary Proteomics for Distinguishing Between Benign and Malignant Ovarian Tumors.
    Ni M; Zhou J; Zhu Z; Yuan J; Gong W; Zhu J; Zheng Z; Zhao H
    Front Cell Dev Biol; 2021; 9():712196. PubMed ID: 34527671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploration of Potential miRNA Biomarkers and Prediction for Ovarian Cancer Using Artificial Intelligence.
    Hamidi F; Gilani N; Belaghi RA; Sarbakhsh P; Edgünlü T; Santaguida P
    Front Genet; 2021; 12():724785. PubMed ID: 34899827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of Serum Metabolites Using MALDI-TOF and Triple-TOF Mass Spectrometry to Develop a Screen for Ovarian Cancer.
    Lee JH; Kim YH; Kim KH; Cho JY; Woo SM; Yoo BC; Kim SC
    Cancer Res Treat; 2018 Jul; 50(3):883-893. PubMed ID: 28934848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples.
    Liu HP; Lai HM; Guo Z
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32607548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test.
    Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y
    Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-1-3p inhibits the growth and metastasis of ovarian cancer cells by targeting DYNLT3.
    Zhu FJ; Li JZ; Wang LL
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8713-8721. PubMed ID: 32964959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer.
    Yao Y; Ding Y; Bai Y; Zhou Q; Lee H; Li X; Teng L
    Front Genet; 2020; 11():591515. PubMed ID: 33597967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer.
    Kumar V; Gupta S; Chaurasia A; Sachan M
    Front Oncol; 2021; 11():681872. PubMed ID: 34692473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum microRNA biomarkers for detection of non-small cell lung cancer.
    Hennessey PT; Sanford T; Choudhary A; Mydlarz WW; Brown D; Adai AT; Ochs MF; Ahrendt SA; Mambo E; Califano JA
    PLoS One; 2012; 7(2):e32307. PubMed ID: 22389695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.